Prota Therapeutics

Series-A
protatherapeutics.com Biotech & Healthcare
Total Funding $10M
Latest Round Undisclosed Series-A
Last Announced Jan 10, 2024
Investors Undisclosed
Decision Makers Profile Active

About Prota Therapeutics

Develops oral immunotherapies for food allergies, focusing on peanut allergy.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website protatherapeutics.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised undisclosed · Series-A

    fundraisingfox.com

  2. Capital Raise

    Raised $10,000,000 · Series-B

    startupintros.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Prota Therapeutics.

Funding History

2 Rounds
Series-A equity · Jan 10, 2024
Series-B equity · Jun 6, 2017

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts